To the Editor—In December 2019, the first cases of a new coronavirus disease (COVID-19)
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were …

To the Editor—The COVID-19 pandemic, caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a public health problem of historic dimensions. However …

Background: The first wave of COVID-19 pandemic may have significantly impacted
antimicrobial consumption in hospitals. The objective of this study was to assess the …

We assessed the antibiotic use in SARS-CoV-2-infected patients during four different waves
of the COVID-19 pandemic, as well as its trends over the period and associated risk factors …

Abstract Introduction: Coronavirus disease 2019 (COVID-19) results in similar clinical
characteristics as bacterial respiratory tract infections and can potentially lead to antibiotic …

During the recent pandemic, the fact that the clinical manifestation of COVID-19 may be
indistinguishable from bacterial infection, as well as concerns of bacterial co-infection, have …

Background: The COVID-19 pandemic poses novel challenges in antimicrobial consumption
metrics and stewardship strategies. COVID-19 patients became the major cause of hospital …

Background Earlier reports suggested high rates of antibiotic utilization among COVID-19
patients despite the lack of direct evidence of their activity against viral pathogens. Different …

Before the coronavirus disease 2019 (COVID-19) pandemic, antimicrobial resistance was
the world's most pressing health crisis. The United Nations, the World Health Organization …

Background There was evidence that antibiotic usage increased in hospitalized COVID-19
patients during the early days of the pandemic. Objective We assessed the impact of …